These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6752331)

  • 21. Prevention of recurrent urinary tract infections in premenopausal women by post-coital administration of cinoxacin.
    Pfau A; Sacks TG; Shapiro M
    J Urol; 1988 Jun; 139(6):1250-2. PubMed ID: 3286892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term low dose cinoxacin therapy for the prevention of recurrent urinary tract infections.
    Landes RR
    J Urol; 1980 Jan; 123(1):47-50. PubMed ID: 7351723
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections.
    Albrecht U; Goos KH; Schneider B
    Curr Med Res Opin; 2007 Oct; 23(10):2415-22. PubMed ID: 17723159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study with cinoxacin, a new drug for the treatment of urinary tract infections].
    Van Vliet P; Denis L
    Acta Urol Belg; 1980 Apr; 48(2):299-302. PubMed ID: 6969979
    [No Abstract]   [Full Text] [Related]  

  • 26. Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy.
    Cox CE; Simmons JR
    South Med J; 1982 May; 75(5):549-50. PubMed ID: 7043747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora.
    Schaeffer AJ; Jones JM; Flynn SS
    J Urol; 1982 Jun; 127(6):1128-31. PubMed ID: 7087019
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of urinary infections: clinical perspectives.
    Fontana G; Laudi M; Carlone NA; Savoia D
    Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of recurrence of repetitious urinary tract infections in women].
    Nihira H; Nakano H
    Nihon Rinsho; 1986 Dec; 44(12):2688-93. PubMed ID: 3546829
    [No Abstract]   [Full Text] [Related]  

  • 30. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
    Raz R; Stamm WE
    N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.
    Sisca TS; Heel RC; Romankiewicz JA
    Drugs; 1983 Jun; 25(6):544-69. PubMed ID: 6347618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of cinoxacin in infections of the urinary tract in ambulatory patients].
    Aimè G; Governa M
    Minerva Urol Nefrol; 1986; 38(2):147-50. PubMed ID: 3750156
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
    Bucy JG
    J Urol; 1981 Jun; 125(6):822-4. PubMed ID: 7017171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of cinoxacin and nalidixic acid in the treatment of chronic urinary tract infections].
    Briedigkeit H; Schimmelpfennig R; Buder R; Precht K; Dröseler H
    Infection; 1982; 10(4):219-22. PubMed ID: 7129643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral resection of the prostate.
    Finkelstein LH; Arsht DB; Manfrey SJ; Childs S
    Am J Surg; 1984 Oct; 148(4A):19-21. PubMed ID: 6091475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.
    Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE
    J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cinobar, a new antimicrobial agent for the treatment of urinary infections].
    Chantrie M
    Acta Urol Belg; 1980 Apr; 48(2):293-7. PubMed ID: 7006345
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of recurrent urinary tract infections in girls.
    Lohr JA; Nunley DH; Howards SS; Ford RF
    Pediatrics; 1977 Apr; 59(4):562-5. PubMed ID: 322082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cinoxacin for urinary tract infections.
    Hatch K
    AUAA J; 1983; 3(3):10-1. PubMed ID: 6226270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.